Join to View Full Profile
225 Clearfield AveVirginia Beach, VA 23462
Phone+1 757-457-5177
Fax+1 757-962-8020
Dr. Given is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of FloridaResidency, Urology, 1993 - 1994
Virginia Commonwealth University Health SystemResidency, Urology, 1990 - 1993- Virginia Commonwealth University Health SystemResidency, Surgery, 1988 - 1990
Virginia Commonwealth University School of MedicineClass of 1988
Certifications & Licensure
NC State Medical License 1995 - 2026
VA State Medical License 1990 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
- Salvage Cryotherapy in Recurrent Prostate Cancer Start of enrollment: 2007 Jan 01
- Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF).Alex M Parker, Vincent G Bird, Shweta Bansal, Amir Kazory, Robert W Given
ASAIO Journal. 2025-12-01 - DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis.Evan Y Yu, Hiroyoshi Suzuki, Christopher M Pieczonka, Geoffrey Gotto, Alberto Briganti
Prostate Cancer and Prostatic Diseases. 2025-11-01 - Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cance...Simon Chowdhury, Anders Bjartell, Neeraj Agarwal, Byung H Chung, Robert W Given
Future Oncology. 2024-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
